Active Recombinant Rhesus IL17RA Protein, His-tagged

• Cat.No.: IL17RA-442R
• Product Overview: Recombinant Rhesus IL17RA (XP_001102483.2) (Met1-Trp320) was expressed with a polyhistidine tag at the C-terminus.

Specification

• Description: Interleukin-17 receptor (IL-17R), also known as Interleukin-17 receptor A (IL-17RA) and CD217 antigen (CD217), is a cytokine receptor which binds interleukin 17. IL-17R/IL-17RA (CD217) is a proinflammatory cytokine secreted by activated T-lymph centigradeytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. IL-17R/IL-17RA (CD217) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor IL-17RA play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Defects in IL-17R/IL-17RA (CD217) are the cause of familial candidiasis type 5 (CANDF5). CANDF5 is a rare disorder with altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.
• Source: HEK293
• Species: Rhesus
• Tag: His
• Predicted N Terminal: Leu 33
• Form: Lyophilized from sterile PBS, pH 7.4. Normally 5 %- 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
• Bio-activity: Measured by its binding ability in a functional ELISA. Immobilized rhesus IL17RA-His at 10μg/mL (100μL/well) can bind biotinylated human IL17A, the EC50 of biotinylated human IL17A is 15-100ng/mL.
• Molecular Mass: The recombinant rhesus IL17RA consists of 309 amino acids and predicts a molecular mass of 35.6 kDa
• Protein length: Met1-Trp320
• Endotoxin: < 1.0 EU per μg protein as determined by the LAL method.
• Purity: > 95 % as determined by SDS-PAGE.
• Storage: Samples are stable for up to twelve months from date of receipt at-70 centigrade. Store it under sterile conditions at-20 centigrade to-80 centigrade. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4℃ before opening to recover the entire contents.
• Official Symbol: IL17RA
• Synonyms: IL17A;interleukin 17A;interleukin-17A

Gene Information

• Official Symbol: IL17RA
• Synonyms: IL17A;interleukin 17A;interleukin-17A

Reviews

01/23/2021

Effective in T-cell activation.

07/12/2019

Suitable for co-immunoprecipitation.

03/17/2017

High solubility.

Q&As

What experimental techniques are employed to investigate the interaction between IL17RA and various IL17 family members, and how is their binding specificity determined?

Surface plasmon resonance, co-immunoprecipitation, and mutagenesis studies reveal IL17RA's binding partners and affinity.

Can you discuss the experimental designs used to examine the crosstalk between IL17RA signaling and other immune pathways, such as TNF-α or IFN-纬 pathways?

Cross-pathway signaling assays, gene expression profiling, and functional rescue experiments unveil IL17RA's interaction networks.

What strategies are utilized to explore the contribution of IL17RA to tissue remodeling processes, such as angiogenesis and fibrosis?

Angiogenesis assays, fibroblast activation assays, and tissue remodeling models illuminate IL17RA's role in tissue repair.

How is the potential of IL17RA as a therapeutic target evaluated in experimental settings, and what challenges exist in translating these findings to clinical applications?

Animal models, pharmacological interventions, and toxicity assessments evaluate IL17RA-targeted therapies and translational challenges.

How do researchers study the involvement of IL17RA in autoimmune disorders through patient samples, and what insights have been gained?

Patient cohorts, clinical data analysis, and immune profiling provide insights into IL17RA's relevance in autoimmune diseases.

How do researchers study the role of IL17RA in the regulation of immune cell recruitment and infiltration in inflammatory tissues?

Flow cytometry, in vivo imaging, and chemotaxis assays characterize immune cell responses guided by IL17RA activation.

Can you elaborate on the methods used to dissect the intracellular signaling pathways triggered by IL17RA activation, especially in the context of autoimmune diseases?

Phosphorylation assays, gene expression analysis, and knockout models dissect IL17RA-mediated signaling cascades.

Could you explain the experimental approaches employed to assess the impact of IL17RA inhibition on chronic inflammatory diseases in preclinical models?

Disease models, antibody-based treatments, and inflammatory biomarker assessments elucidate IL17RA's therapeutic potential.

What molecular methods are employed to understand the genetic and epigenetic regulation of IL17RA expression in immune cells?

ChIP-sequencing, promoter analysis, and epigenetic modification studies uncover IL17RA gene regulation mechanisms.

What techniques are used to investigate the role of IL17RA in maintaining epithelial barrier integrity and preventing microbial invasion?

Epithelial barrier assays, microbiome analysis, and infection models decipher IL17RA's role in mucosal defense.